NCT04243577

Brief Summary

Wearable tele-rehabilitation technology allows for the efficient provision of rehabilitation services from a distance, facilitating tele-management of many disorders. The proposed research will develop and validate a set of mechanically compliant, easy-to-use, and inexpensive wearable tele-monitoring systems, for future use in the rehabilitation of swallowing disorders (dysphagia). The hypothesis is that the newly developed wearable sensors will have equal or better performance than traditional wired sensors used today in clinical practice. Factors related to signal quality and patient reported outcomes (e.g., satisfaction/comfort level, adverse effects etc.) will be examined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Sep 2018

Longer than P75 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 11, 2018

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2019

Completed
5 months until next milestone

First Posted

Study publicly available on registry

January 28, 2020

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2023

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

August 14, 2024

Completed
Last Updated

August 14, 2024

Status Verified

July 1, 2024

Enrollment Period

4.6 years

First QC Date

August 26, 2019

Results QC Date

May 21, 2024

Last Update Submit

July 18, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Normalized Task-related sEMG Amplitude (Signal Quality Parameter)

    Normalized sEMG amplitude values during standardized swallow tasks and maneuvers will be recorded and compared between the two sEMG devices. Normalized amplitude is used as a signal quality parameter and is not a health related outcome.

    Post each experiment (i.e., 1 hour after the sensors have been placed)

  • Signal to Noise Ratio (Signal Quality Parameter)

    Signal to Noise ratio will be calculated and compared between sensor types tested. Signal to noise ration is a signal quality parameter and not a health related outcome.

    Post each experiment (i.e., 1 hour after the sensors have been placed)

Secondary Outcomes (2)

  • Ease of Use/Comfort

    Post each experiment (i.e., 1 hour after the sensors have been placed)

  • Adverse Effects and Safety

    Pre and Post each experiment (i.e., right before the placement of sensors on the subject and 1 hour after the sensors have been placed and 5 minutes after their removal)

Study Arms (2)

Group A: Conventional Sensors First, Then Experimental (Tele-EaT) Sensors

OTHER

Group A participants will complete the experimental protocol (swallow trials) with the conventional (commercially available) electrodes/sensors first. After a break of 10 minutes, they then will repeat the exact same experimental protocol (exact same swallow trials) with the experimental sensors (i.e., a wearable surface EMG sensors patch we are developing).

Device: Tele-EaT SensorsDevice: Conventional Sensors

Group B: Experimental (Tele-EaT) Sensors First, Then Conventional Sensors

OTHER

Group B participants will complete the experimental protocol (swallow trials) with the experimental sensors (i.e., a wearable surface EMG sensors patch we are developing) first. After a break of 10 minutes, they then will repeat the exact same experimental protocol (exact same swallow trials) with the conventional (commercially available) electrodes/sensors.

Device: Tele-EaT SensorsDevice: Conventional Sensors

Interventions

Two iterations of a wearable surface EMG (sEMG) sensors patch we developed will be tested against commercially available wired devices. The first iteration of the wearable sensor patch is an ultrathin patch with a honeycomb-inspired design that included sEMG and strain sensors in order to capture muscle activity and thyroid movement signals from the submental area during swallows and swallow maneuvers/exercises. The second iteration is a more durable slightly thicker flexible, non-stretchable, and double-sided thin sEMG patch. Participants will perform standardized swallow tasks while wearing the device.

Group A: Conventional Sensors First, Then Experimental (Tele-EaT) SensorsGroup B: Experimental (Tele-EaT) Sensors First, Then Conventional Sensors

Conventional sensors will include snap-on wired electrodes as the control condition. The same set of standardized swallow tasks will be completed with the conventional and commercially available devices as well.

Group A: Conventional Sensors First, Then Experimental (Tele-EaT) SensorsGroup B: Experimental (Tele-EaT) Sensors First, Then Conventional Sensors

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-30 OR 50-90 years of age
  • No history of dysphagia
  • No history of a neurological disorder
  • A score in the normal/mild range on the Montreal Cognitive Assessment (MoCA):
  • A score of \<3 on the Eating Assessment Tool-10 (EAT-10, a self-report screening for dysphagia).
  • Age 18-90 years of age
  • Diagnoses of dysphagia as a result of a neurological disorder (e.g., stroke, Parkinson's disease).
  • A score in the normal/mild range on the Montreal Cognitive Assessment (MoCA).
  • A score of ≥3 on the Eating Assessment Tool-10 (EAT-10, a self-report screening for dysphagia).

You may not qualify if:

  • Significant cognitive impairment (a score in the moderate-severe range on MoCA):

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Purdue University I-EaT Lab

West Lafayette, Indiana, 47907, United States

Location

MeSH Terms

Conditions

Deglutition Disorders

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Results Point of Contact

Title
Georgia Malandraki
Organization
Purdue University

Study Officials

  • Georgia A. Malandraki, PhD

    Professor

    PRINCIPAL INVESTIGATOR
  • Chi Hwan Lee, PhD

    Associate Professor

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: Experiments will follow a within-subject randomized cross-over design. The purpose is to develop devices that are optimized for their use. To achieve this goal, for each new iteration of the devices, at least ten new participants will be tested using the current prototypes and the commercially available counterpart sensors in counterbalanced order. Results will be analyzed and discussed in regards to design improvements before the next iteration of development. The plan to recruit a large number of total subjects allows for several pre-clinical experiments to be conducted until the final versions of both devices are optimized.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Department of Speech, Language and Hearing Sciences

Study Record Dates

First Submitted

August 26, 2019

First Posted

January 28, 2020

Study Start

September 11, 2018

Primary Completion

March 31, 2023

Study Completion

July 25, 2023

Last Updated

August 14, 2024

Results First Posted

August 14, 2024

Record last verified: 2024-07

Locations